Hazardous use of sedatives, hypnotics or anxiolytics (Q50799): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Padrão de uso de sedativos, hipnóticos ou ansiolíticos que aumenta consideravelmente o risco de consequências nocivas à saúde física ou mental para o usuário ou para outras pessoas numa medida que merece atenção e aconselhamento por profissionais de saúde. O risco aumentado pode decorrer da frequência de uso de sedativos, hipnóticos ou ansiolíticos, da quantidade usada em determinada ocasião, de comportamentos de risco associados ao uso de sedativos, hipnóticos ou ansiolíticos ou do contexto de uso, de uma via de administração nociva ou de uma combinação desses fatores. O risco pode estar relacionado com efeitos de curto prazo dos sedativos, hipnóticos ou ansiolíticos ou com efeitos cumulativos de longo prazo sobre a saúde física ou mental, ou a funcionalidade. O uso perigoso de sedativos, hipnóticos ou ansiolíticos ainda não atingiu o nível de ter causado danos à saúde física ou mental do usuário ou de outras pessoas em seu entorno. O padrão de uso de sedativos, hipnóticos ou ansiolíticos frequentemente persiste apesar da conscientização do aumento do risco de danos ao usuário ou a outras pessoas. | |||||||||||||||
| description / en | description / en | ||||||||||||||
A pattern of use of sedatives, hypnotics or anxiolytics that appreciably increases the risk of harmful physical or mental health consequences to the user or to others to an extent that warrants attention and advice from health professionals. The increased risk may be from the frequency of use of sedatives, hypnotics or anxiolytics, from the amount used on a given occasion, from risky behaviours associated with use of sedatives, hypnotics or anxiolytics or the context of use, from a harmful route of administration, or from a combination of these. The risk may be related to short-term effects of sedatives, hypnotics or anxiolytics or to longer-term cumulative effects on physical or mental health or functioning. Hazardous use of sedatives, hypnotics or anxiolytics has not yet reached the level of having caused harm to physical or mental health of the user or others around the user. The pattern of use of sedatives, hypnotics or anxiolytics often persists in spite of awareness of increased risk of harm to the user or to others. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/756014816 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:QE11.2 | |||||||||||||||
| Property / CURIE: CID11:QE11.2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-QE11.2 | |||||||||||||||
| Property / Canary Token: dki-india-QE11.2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: Z72.2 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 21:45, 13 August 2026
A pattern of use of sedatives, hypnotics or anxiolytics that appreciably increases the risk of harmful physical or mental health consequences to the user or to others to an extent that warrants attention and advice from health professionals. The increased risk may be from the frequency of use of sedatives, hypnotics or anxiolytics, from the amount used on a given occasion, from risky behaviours associated with use of sedatives, hypnotics or anxiolytics or the context of use, from a harmful route of administration, or from a combination of these. The risk may be related to short-term effects of sedatives, hypnotics or anxiolytics or to longer-term cumulative effects on physical or mental health or functioning. Hazardous use of sedatives, hypnotics or anxiolytics has not yet reached the level of having caused harm to physical or mental health of the user or others around the user. The pattern of use of sedatives, hypnotics or anxiolytics often persists in spite of awareness of increased risk of harm to the user or to others.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | QE11.2 |
||
| English | Hazardous use of sedatives, hypnotics or anxiolytics |
A pattern of use of sedatives, hypnotics or anxiolytics that appreciably increases the risk of harmful physical or mental health consequences to the user or to others to an extent that warrants attention and advice from health professionals. The increased risk may be from the frequency of use of sedatives, hypnotics or anxiolytics, from the amount used on a given occasion, from risky behaviours associated with use of sedatives, hypnotics or anxiolytics or the context of use, from a harmful route of administration, or from a combination of these. The risk may be related to short-term effects of sedatives, hypnotics or anxiolytics or to longer-term cumulative effects on physical or mental health or functioning. Hazardous use of sedatives, hypnotics or anxiolytics has not yet reached the level of having caused harm to physical or mental health of the user or others around the user. The pattern of use of sedatives, hypnotics or anxiolytics often persists in spite of awareness of increased risk of harm to the user or to others. |
Statements
CID11:QE11.2
0 references
dki-india-QE11.2
0 references
Concluído
0 references
13 August 2026
0 references
